Grants and Contributions:
Title:
195243
Agreement Number:
195243
Agreement Value:
$3,396,394.00
Agreement Date:
Sep 10, 2010 - Dec 30, 2014
Description:
Soricidin-Derived Peptides for Targeted Cancer Management
Organization:
Atlantic Canada Opportunities Agency
Location:
Moncton, New Brunswick, CA E1C 4W7
Reference Number:
276-2010-2011-Q2-00288
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Additional Information:
The grant or contribution awarded has been amended; the previous value was $2,896,394.00.
Amendment Date
Sep 16, 2014
Recipient's Legal Name:
Soricimed Biopharma Inc.
Program:
Atlantic Innovation Fund (AIF) - II
Amendments: